Adenosine receptors in COPD and asymptomatic smokers: Effects of smoking cessation

Virchows Archiv

Volumn 454, Issue 3, 2009, Pages 273-281

  Versluis, Mieke ^a   Ten Hacken, Nick ^a   Postma, Dirkje ^a   Barroso, Begona ^a   Rutgers, Bea ^a   Geerlings, Marie ^a   Willemse, Brigitte ^a   Timens, Wim ^a   Hylkema, MacHteld ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Adenosine; Adenosine receptors; COPD; Smoking cessation

Indexed keywords

ADENOSINE RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN;

ADULT; ARTICLE; BRONCHUS BIOPSY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MACROPHAGE; MALE; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SMOKING CESSATION; SPUTUM; SUPERNATANT;

ADENOSINE; ADULT; BRONCHOSCOPY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE PROGRESSION; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, PURINERGIC P1; SMOKING; SMOKING CESSATION; SPUTUM;

EID: 65149091120     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-009-0727-9     Document Type: Article

References (28)

1. KF Rabe S Hurd A Anzueto 2007 Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 176 532 555 (Pubitemid 47403272)
2. NR Anthonisen JE Connett JP Kiley 1994 Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study JAMA 272 1497 1505 (Pubitemid 24986688)
3. RE Kanner JE Connett DE Williams 1999 Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study Am J Med 106 410 416 (Pubitemid 29190593)
4. BW Willemse NH ten Hacken B Rutgers 2004 Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD Eur Respir J 24 391 396 (Pubitemid 39232261)
5. BW Willemse NH ten Hacken B Rutgers 2005 Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers Eur Respir J 26 835 845 (Pubitemid 41632040)
6. R Polosa 2002 Adenosine-receptor subtypes: their relevance to adenosine-mediated responses in asthma and chronic obstructive pulmonary disease Eur Respir J 20 488 496
7. Y Oosterhoff JW de Jong MA Jansen 1993 Airway responsiveness to adenosine 5'-monophosphate in chronic obstructive pulmonary disease is determined by smoking Am Rev Respir Dis 147 553 558 (Pubitemid 23072641)
8. Y Oosterhoff MA Jansen DS Postma 1993 Airway responsiveness to adenosine 5'-monophosphate in smokers and nonsmokers with atopic asthma J Allergy Clin Immunol 92 773 776 (Pubitemid 23343788)
9. AG Driver CA Kukoly S Ali 1993 Adenosine in bronchoalveolar lavage fluid in asthma Am Rev Respir Dis 148 91 97 (Pubitemid 23187224)
10. K Varani G Caramori F Vincenzi 2006 Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 173 398 406 (Pubitemid 43228327)
11. Cronstein BN (1994) Adenosine, an endogenous anti-inflammatory agent. 76:5-13
12. BN Cronstein L Daguma D Nichols 1990 The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively J Clin Invest 85 1150 1157 (Pubitemid 20123757)
13. G Hasko C Szabo ZH Nemeth 1996 Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice J Immunol 157 4634 4640 (Pubitemid 126449386)
14. O Le Moine P Stordeur L Schandene 1996 Adenosine enhances IL-10 secretion by human monocytes J Immunol 156 4408 4414 (Pubitemid 26165841)
15. BW Willemse NH ten Hacken B Rutgers 2005 Association of current smoking with airway inflammation in chronic obstructive pulmonary disease and asymptomatic smokers Respir Res 6 38 (Pubitemid 41358032)
16. BR Celli W [tmp] MacNee 2004 Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper Eur Respir J 23 932 946 (Pubitemid 38807371)
17. RM Aleva J Kraan M Smith 1998 Techniques in human airway inflammation: quantity and morphology of bronchial biopsy specimens taken by forceps of three sizes Chest 113 182 185 (Pubitemid 28044944)
18. SR Rutgers W Timens HF Kaufmann 2000 Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD Eur Respir J 15 109 115 (Pubitemid 30068945)
19. V Ralevic G Burnstock 1998 Receptors for purines and pyrimidines Pharmacol Rev 50 413 492 (Pubitemid 28477681)
20. BB Fredholm G Arslan L Halldner 2000 Structure and function of adenosine receptors and their genes Naunyn Schmiedebergs Arch Pharmacol 362 364 374
21. N Bevan PR Butchers R Cousins 2007 Pharmacological characterisation and inhibitory effects of (2R,3R,4S,5R)-2-(6-amino-2-{[(1S)-2-hydroxy-1- (phenylmethyl)ethyl]amino}-9 H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl) tetrahydro-3,4-furandiol, a novel ligand that demonstrates both adenosine A(2A) receptor agonist and adenosine A(3) receptor antagonist activity Eur J Pharmacol 564 219 225 (Pubitemid 46950873)
22. Y Chen R Corriden Y Inoue 2006 ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors Science 314 1792 1795
23. AN Clark R Youkey X Liu 2007 A1 adenosine receptor activation promotes angiogenesis and release of VEGF from monocytes Circ Res 101 1075 7077 (Pubitemid 350146439)
24. J Zhu YS Qiu S Majumdar 2001 Exacerbations of Bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants Am J Respir Crit Care Med 164 109 116 (Pubitemid 33151307)
25. N Rovina A Papapetropoulos A Kollintza 2007 Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease? Respir Res 8 53
26. H Kanazawa K Asai K Hirata 2003 Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease Am J Med 114 354 358 (Pubitemid 36513682)
27. H Kanazawa K Asai S Nomura 2007 Vascular endothelial growth factor as a non-invasive marker of pulmonary vascular remodeling in patients with bronchitis-type of COPD Respir Res 8 22
28. T Wasada R Kawahara K Katsumori 1998 Plasma concentration of immunoreactive vascular endothelial growth factor and its relation to smoking Metabolism 47 27 30 (Pubitemid 28086228)